comparison of glp 1 agonists GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Glucagon-Like Peptide 1 Receptor Agonists
Description
In animal studies, glucagon-like peptide-1 receptor agonists consistently reduce drug intake, attenuate dopamine release in reward circuits, and decrease relapse-like behavior
Although the mean follow-up among GLP1 receptor agonist users was 3.9 years, because of cancer latency,13 extended follow-up might be needed to detect an increased risk
(Lausanne) 11 , 622589 (2020)
doi: 10.1016/j.mce.2015.01.030 268 ChenLKongC
